Wednesday, April 1, 2026
22.3 C
Bengaluru

Frontline Managers

[wpfilebase tag=file id=62 tpl=download-button /]

Inside this Issue

1. Parle-G: Still Number One by Vivek Hattangadi

How this 80 year old brand still has 80 percent market share.

2. The University of Pharma Sales by Raja Reddy

What the author learned about success and life on his journey from Medical Representative to Group Product Manager.

3. Nine Accountability Boosters for Frontline Managers by K. Hariram

9 habits that will inspire the confidence of your team members in your Leadership.

4. Bridging the Trust Deficit by Satish Kota

Indian Pharma has contributed immensely to society but needs an image makeover to change negative perceptions.

5. Impact of Frontline Leadership on Efficiency: A Case Study by P. S. Parameswaran

The actions of the Frontline Manager, more than anything else, has a direct impact on how employees perform.

6. Cost-Effective Learning by Gopal Kishore

Using technology to make learning personalized is both cost effective and impactful.

7. Smart Pills by Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal, Mahendra Kumar Rai

Are ingestible sensors the next big thing in patient adherence?

Hot this week

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled

From Gas Cylinders to ICU Beds: How the Gulf...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

As over 50 generic versions of the blockbuster weight-loss...

Excellence or Mediocrity—What Are You Building?

Excellence is a choice. So is Mediocrity Excellence is a...

Topics

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

As over 50 generic versions of the blockbuster weight-loss...

Excellence or Mediocrity—What Are You Building?

Excellence is a choice. So is Mediocrity Excellence is a...

Gila Monster Venom: The Unexpected Spark of the GLP-1 Revolution

In the blistering Sonoran Desert, where temperatures regularly exceed...

The Quiet Crisis in the Indian Pharma Field Force

A MedicinMan Editorial based on the Poll framed by...
spot_img

Related Articles

spot_imgspot_img